FDA Looks To Expand Drug GMPs Farther Up The Pharmaceutical Supply Chain
Executive Summary
FDA is looking to assert its regulatory authority farther up the pharmaceutical supply chain with new regulatory GMP requirements and an expansive interpretation of International Conference on Harmonization guidelines